NCT05738577View on ClinicalTrials.gov

Apelin as a Marker of Early Complications in Type 1 Diabetes Mellitus

Not yet recruitingOBSERVATIONAL

Enrollment

90

Participants

Timeline

Start Date

February 25, 2023

Primary Completion Date

December 1, 2024

Study Completion Date

December 1, 2025

Conditions

Diabetes Mellitus, Type 1

All Listed Sponsors

lead

Assiut University

OTHER

NCT05738577 - Apelin as a Marker of Early Complications in Type 1 Diabetes Mellitus | Biotech Hunter | Biotech Hunter